Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study.
Saved in:
| Title: | Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study. |
|---|---|
| Authors: | Gernaat SAM; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. sofie.gernaat@gmail.com., von Stedingk H; Goodpoint AB, Stockholm, Sweden., Hassan M; Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden., Nilsson HP; Adduct Analys, Södertälje, Sweden., Rodriguez-Wallberg KA; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Department of Gynecology and Reproduction, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Hedayati E; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Medical Unit of Breast Cancer, Sarcoma and Endocrine Tumours, Theme Cancer, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Rydberg P; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. |
| Source: | Scientific reports [Sci Rep] 2021 Feb 01; Vol. 11 (1), pp. 2707. Date of Electronic Publication: 2021 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-021-81662-1 |
